Home › Funds › Renaissance Technologies › CGEM

Renaissance Technologies position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

Latest position (Q2 2026)326.81K sh
Reported value held$5.95M
Portfolio Weight0.01%
First reportedQ4 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q4 2021 26.60K $410.00K New
Q2 2022 293.60K $3.76M New
Q3 2022 302.19K $3.87M Add
Q4 2022 307.70K $3.25K Add
Q1 2023 239.20K $2.45K Reduce
Q2 2023 245.60K $2.64K Add
Q3 2023 222.70K $2.02K Reduce
Q4 2023 264.09K $2.69K Add
Q1 2024 321.10K $5.47K Add
Q2 2024 421.71K $7.35M Add
Q3 2024 281.80K $4.72M Reduce
Q4 2024 190.51K $2.32M Reduce
Q1 2025 363.01K $2.75M Add
Q1 2025 363.01K $2.75M Add
Q2 2025 334.52K $2.52M Reduce
Q2 2025 334.52K $2.52M Reduce
Q3 2025 529.41K $3.14M Add
Q4 2025 631.71K $6.54M Add
Q1 2026 324.11K $4.61M Reduce
Q2 2026 326.81K $5.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding CGEM

All CGEM fund holders →